published in
- Frontiers in aging Journal
The lifespan-extending MEK1 inhibitor trametinib promotes regulation of de novo lipogenesis enzymes by chaperone-mediated autophagy.
- Overview
- Research
- Identity
- Additional Document Info
- View All